Posted Feb. 9, 2010 at 11:51 a.m.
Pappas Ventures
Pappas Ventures-backed pharma startup raises $9 million
Post a comment
Print this blog postE-mail blog post
Share
Pappas Ventures
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
DURHAM, N.C. - Syndax Pharmaceuticals, which is backed by Triangle-based Pappas Ventures, has raised $9 million as part of a new $16 million round, according to a filing with the Securities and Exchange Commission.
Syndax, which is developing treatments to combat cancer, is based in Waltham, Mass. It raised $40 million in 2007 with Pappas Ventures among the backers.
Copyright 2012 WRAL Tech Wire. All rights reserved.
Featured
E-mail Preferences
The Skinny
- Who won 'Social Bowl'? Super Bowl ads paying fans to play
- RTP broadband firm Overture, minus two top execs, launches new look
- Will RTP-based ChannelAdvisor go public? They're thinking
- What brands are winning Super Bowl hype? Two Durham firms to find out
- In Super Bowl of social media, Patriots win, Triangle firm says
- Big job cuts coming at IBM? Don't be surprised
- Erskine Bowles is among those who can cash in big time on Facebook IPO
- Ignore Facebook hype - Check out 'risk factors,' too
- Facebook vs. Google IPO: Which deal ranks better?
- Triangle StartUp Factory says business already booming